Have a personal or library account? Click to login
Impact of Pulmonary Arterial Hypertension on Left Ventricular Function – a Comparative Study between Scleroderma and Coronary Artery Disease Cover

Impact of Pulmonary Arterial Hypertension on Left Ventricular Function – a Comparative Study between Scleroderma and Coronary Artery Disease

Open Access
|Dec 2018

References

  1. 1. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34-D41.10.1016/j.jacc.2013.10.02924355639
  2. 2. Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013;144:1346-1356.10.1378/chest.12-2396378792024081346
  3. 3. Tedford R, Mudd J, Girgis R, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013;6:953-963.10.1161/CIRCHEARTFAILURE.112.000008381569723797369
  4. 4. Nguyen C, Bérezné A, Baubet T, et al. Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS One. 2011;6:e17551.10.1371/journal.pone.0017551305231921408076
  5. 5. Le Pavec J, Humbert M, Mouthon L, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181:1285-1293.10.1164/rccm.200909-1331PP289440720194816
  6. 6. Ryan JJ, Thenappan T, Luo N, et al. The WHO classification of pulmonary hypertension: A case-based imaging compendium. Pulm Circ. 2012;2:107-121.10.4103/2045-8932.94843334273922558526
  7. 7. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement and systemic sclerosis. Lupus. 2005;14:702-707.10.1191/0961203305lu2204oa16218471
  8. 8. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989-2003.10.1056/NEJMra080618819420368
  9. 9. Fernandes F, Ramires FJ, Arteaga E, et al. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003;9:311-317.10.1054/jcaf.2003.5113680552
  10. 10. Plazak W, Zabinska-Plazak E, Wojas-Pelc A, et al. Heart structure and function in systemic sclerosis. Eur J Dermatology. 2002;12:257-262.
  11. 11. Lindqvist P, Caidahl K, Neuman-Andersen G, et al. Disturbed right ventricular diastolic function in patients with systemic sclerosis. A Doppler tissue imaging study. Chest. 2005;128:755-763.10.1378/chest.128.2.75516100164
  12. 12. Durmus E, Sunbul M, Tigen K, et al. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension: speckle-tracking echocardiographic study. Herz. 2014;40:709-715.10.1007/s00059-014-4113-2
  13. 13. Hirooka K, Naito J, Koretsune Y, et al. Analysis of transmural trends in myocardial integrated backscatter in patients with progressive systemic sclerosis. J Am Soc Echocardiogr. 2003;16:340-346.10.1016/S0894-7317(02)74427-1
  14. 14. D’Angelo WA, Fries JF, Masi AT, et al. Pathological observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls. Am J Med. 1969;46:428-440.10.1016/0002-9343(69)90044-8
  15. 15. Gaasch W, Zile M. Left Ventricular Diastolic Dysfunction and Diastolic Heart Failure. Annual Review of Medicine. 2004;55:373-394.10.1146/annurev.med.55.091902.104417
  16. 16. Allman K, Shaw L, Hachamovitch R, Udelson J. Myocardial Viability Testing and Impact of Revascularization on Prognosis in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: A Meta-Analysis. J Am Coll Cardiol. 2002;39:1151-1158.10.1016/S0735-1097(02)01726-6
  17. 17. Beller GA. Noninvasive assessment of myocardial viability. N Engl J Med. 2000;343:1488-1490.10.1056/NEJM20001116343201111078777
  18. 18. Bulkley BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis, a cause of cardiac dysfunction. Circulation. 1976;53:483-490.10.1161/01.CIR.53.3.483
  19. 19. Armstrong GP, Whalley GA, Doughty RN, et al. Left ventricular function in scleroderma. Br J Rheumatol. 1996;35:983-988.10.1093/rheumatology/35.10.9838883437
  20. 20. Candell-Riera J, Armadans-Gil L, Simeon CP, et al. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum. 1996;39:1138-1145.10.1002/art.17803907108670322
  21. 21. Turiel M, Gianturco L, Ricci C, et al. Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study. Arthritis Care Res (Hoboken). 2012;65:274-280.10.1002/acr.2181922899452
  22. 22. Fernandes F, Ramires FJ, Arteaga E, Ianni BM, Bonfa ES, Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail. 2003;9:311-317.10.1054/jcaf.2003.51
  23. 23. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology. 2006;45:iv14-iv17.10.1093/rheumatology/kel312
  24. 24. Wang M, Yip GW, Wang AY, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003;41:820-826.10.1016/S0735-1097(02)02921-2
  25. 25. De Groote P, Gressin V, Hachulla E, et al. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis. 2008;67:31-36.10.1136/ard.2006.05776017267515
  26. 26. Olivotti L, Cosmi D, Nicolino A, Martinelli L, Moshiri S, Danzi GB. Large Left Ventricular Aneurysm and Multifocal Myocardial Involvement in a Patient with Systemic Sclerosis. Can J Cardiol. 2017;33:950.e5-950.e6.10.1016/j.cjca.2017.03.01728668148
  27. 27. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165-193.10.1093/ejechocard/jep00719270053
  28. 28. Hinchcliff M, Desai CS, Varga J, Shah SJ. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin Exp Rheumatol. 2012;30:S30-S37.
  29. 29. Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Archives of Cardiovascular Diseases. 2010;103:46-52.10.1016/j.acvd.2009.06.00920142120
  30. 30. Yiu KH, Schouffoer AA, Marsan NA. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias. Arthritis Rheum. 2011;63:3969-3978.10.1002/art.3061422127711
  31. 31. Meune C, Avouac J, Wahbi K, et al.Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum. 2008;58:1803-1809.10.1002/art.2346318512815
DOI: https://doi.org/10.2478/jim-2018-0028 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Language: English
Page range: 173 - 180
Submitted on: Aug 7, 2018
Accepted on: Sep 3, 2018
Published on: Dec 19, 2018
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Roxana Cucuruzac, Emese Marton, Roxana Hodas, Ciprian Blendea, Mirela Pirvu, Annabella Benedek, Theodora Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.